{"id":"https://openalex.org/W2582860375","doi":"https://doi.org/10.1182/blood.v126.23.619.619","title":"A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study","display_name":"A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2582860375","doi":"https://doi.org/10.1182/blood.v126.23.619.619","mag":"2582860375"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.619.619","doi":"https://doi.org/10.1182/blood.v126.23.619.619","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.619.619","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103116246","display_name":"Shalini S. Shenoy","orcid":"https://orcid.org/0000-0002-9283-607X","observed_orcids":["https://orcid.org/0000-0002-9283-607X"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shalini Shenoy","raw_affiliation_strings":["Department of Pediatrics, Washington University School of Medicine, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Washington University School of Medicine, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041346359","display_name":"Mary Eapen","orcid":"https://orcid.org/0000-0001-6193-4243","observed_orcids":["https://orcid.org/0000-0001-6193-4243"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Eapen","raw_affiliation_strings":["Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101748080","display_name":"Juan Wu","orcid":"https://orcid.org/0000-0002-1860-6591","observed_orcids":["https://orcid.org/0000-0002-1860-6591"]},"institutions":[{"id":"https://openalex.org/I4210115849","display_name":"Emmes (United States)","ror":"https://ror.org/027fvqp63","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115849"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan Wu","raw_affiliation_strings":["The Emmes Corporation, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Emmes Corporation, Rockville, MD","institution_ids":["https://openalex.org/I4210115849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040299600","display_name":"Mark C. Walters","orcid":"https://orcid.org/0000-0002-6515-4559","observed_orcids":["https://orcid.org/0000-0002-6515-4559"]},"institutions":[{"id":"https://openalex.org/I4210135903","display_name":"UCSF Benioff Children's Hospital","ror":"https://ror.org/03hwe2705","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135903"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark C. Walters","raw_affiliation_strings":["UCSF Benioff Children's Hospital, Oakland, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Benioff Children's Hospital, Oakland, CA","institution_ids":["https://openalex.org/I4210135903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043877705","display_name":"John E. Levine","orcid":"https://orcid.org/0000-0002-5611-7828","observed_orcids":["https://orcid.org/0000-0002-5611-7828"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]},{"id":"https://openalex.org/I4390039285","display_name":"U-M Rogel Cancer Center","ror":"https://ror.org/05asdy483","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445","https://openalex.org/I4390039285"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John E. Levine","raw_affiliation_strings":["5303 Cancer Center, Univ. of Michigan Medical Ctr., Ann Arbor, MI","Blood and Marrow Transplant Program, Mount Sinai School of Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5303 Cancer Center, Univ. of Michigan Medical Ctr., Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445","https://openalex.org/I4390039285"]},{"raw_affiliation_string":"Blood and Marrow Transplant Program, Mount Sinai School of Medicine, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025687838","display_name":"Brent R. Logan","orcid":"https://orcid.org/0000-0002-4473-4044","observed_orcids":["https://orcid.org/0000-0002-4473-4044"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brent Logan","raw_affiliation_strings":["Division of biostatistics, Medical College of Wisconsin, Milwuakee, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of biostatistics, Medical College of Wisconsin, Milwuakee, WI","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074398879","display_name":"Iris D. Gersten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115849","display_name":"Emmes (United States)","ror":"https://ror.org/027fvqp63","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115849"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Iris D. Gersten","raw_affiliation_strings":["The Emmes Corporation, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Emmes Corporation, Rockville, MD","institution_ids":["https://openalex.org/I4210115849"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030651735","display_name":"Naynesh R. Kamani","orcid":"https://orcid.org/0000-0003-1582-8874","observed_orcids":["https://orcid.org/0000-0003-1582-8874"]},"institutions":[{"id":"https://openalex.org/I2800759093","display_name":"American Association of Blood Banks","ror":"https://ror.org/036bpjh12","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800759093"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naynesh R. Kamani","raw_affiliation_strings":["AABB Center for Cellular Therapies, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AABB Center for Cellular Therapies, Washington, DC","institution_ids":["https://openalex.org/I2800759093"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.925,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.870123,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":97},"biblio":{"volume":"126","issue":"23","first_page":"619","last_page":"619"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.5932999849319458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.5932999849319458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.39480000734329224,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9700000286102295},{"id":"https://openalex.org/keywords/unrelated-donor-transplantation","display_name":"unrelated donor transplantation","score":0.753000020980835},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.9929999709129333},{"id":"https://openalex.org/keywords/allogeneic-bone-marrow-transplantation","display_name":"allogeneic bone marrow transplantation","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.7870000004768372},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.8809999823570251},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.9929999709129333},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.9049999713897705},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8199999928474426},{"id":"https://openalex.org/keywords/vaso-occlusive-pain","display_name":"vaso-occlusive pain","score":0.656000018119812},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.5249999761581421},{"id":"https://openalex.org/keywords/acute-chest-syndrome","display_name":"acute chest syndrome","score":0.777999997138977},{"id":"https://openalex.org/keywords/donor-engraftment","display_name":"donor engraftment","score":0.753000020980835},{"id":"https://openalex.org/keywords/transplant-related-toxicity","display_name":"transplant toxicity","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8219749927520752},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.6103829145431519},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5708105564117432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5384732484817505},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.4720630943775177},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4690179228782654},{"id":"https://openalex.org/C2780976302","wikidata":"https://www.wikidata.org/wiki/Q4677915","display_name":"Acute chest syndrome","level":4,"score":0.4534280002117157},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4528939127922058},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4328817129135132},{"id":"https://openalex.org/C2775965419","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter trial","level":4,"score":0.4258619546890259},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33412039279937744},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.324060320854187},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.2154323160648346},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.20429134368896484},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20219984650611877},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.19372305274009705},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.11988991498947144},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.11717760562896729},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.619.619","doi":"https://doi.org/10.1182/blood.v126.23.619.619","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.619.619","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2516077920","https://openalex.org/W7154733725","https://openalex.org/W2041475104","https://openalex.org/W2046151274","https://openalex.org/W2552002719","https://openalex.org/W2909482306","https://openalex.org/W4389455886","https://openalex.org/W1999484550","https://openalex.org/W4417012809","https://openalex.org/W2988618155"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Children":[2,150],"with":[3,51,97,292,454,473,556,580],"severe":[4,557],"sickle":[5],"cell":[6],"disease":[7,28,132,225],"(SCD)":[8],"experience":[9],"organ":[10,565],"damage,":[11],"poor":[12],"quality":[13,635],"of":[14,19,73,146,156,191,229,296,346,353,365,384,419,495,505,512,527,551,563,572,577,582,588,608,615,636],"life,":[15],"and":[16,58,116,131,153,204,209,221,239,241,259,309,326,368,377,438,456,491,498,517,574,610,617,638,646],"a":[17,54,81,268,425,569],"risk":[18,587],"premature":[20],"mortality.":[21,618],"Allogeneic":[22],"bone":[23],"marrow":[24],"transplantation":[25],"(BMT)":[26],"halts":[27],"progression":[29],"when":[30,400],"stable":[31],"donor":[32,44,57,94,114,601],"erythropoiesis":[33],"is":[34,46],"established.":[35],"Myeloablative":[36],"conditioning":[37,100],"(MAC)":[38],"followed":[39,328],"by":[40,329,404],"HLA":[41,91,215],"matched":[42,55,92,212],"sibling":[43,56,600],"BMT":[45,96,553],"effective,":[47],"but":[48],"most":[49],"patients":[50,136,254,277,303,320,414,471,508,535,609],"SCD":[52,558,583],"lack":[53],"long":[59],"term":[60],"side":[61],"effects":[62],"from":[63,245,265,287,443],"MAC":[64],"(e.g.,":[65],"infertility)":[66],"can":[67],"be":[68,111],"barriers":[69],"to":[70,87,196,202,594],"patient":[71,262,478],"acceptance":[72],"BMT.":[74,420,602,629],"The":[75,120,187,339,350,361,382,431,586],"SCURT":[76],"trial":[77,86,550],"was":[78,123,263,327,342,357,389,393,402,592,611],"designed":[79],"as":[80],"prospective,":[82],"multicenter":[83],"phase":[84],"II":[85],"evaluate":[88],"outcomes":[89],"after":[90,249,424,597,627],"unrelated":[93],"(MUD)":[95],"reduced":[98],"intensity":[99],"(RIC).":[101],"We":[102],"hypothesized":[103],"that":[104,595],"an":[105],"intensely":[106],"immunosuppressive":[107,539],"RIC":[108,545],"regimen":[109,189,546],"would":[110],"sufficient":[112],"for":[113,139,143,267,428],"engraftment":[115],"could":[117],"limit":[118],"toxicity.":[119],"primary":[121,141,340],"endpoint":[122,142,341],"one":[124],"year":[125],"event":[126],"free":[127],"survival":[128,355],"(EFS)":[129],"(alive":[130],"free)":[133],"\u226575%.":[134],"All":[135,302,460],"were":[137,179,211,255,290,375,409,462,489],"evaluable":[138,291],"the":[140,144,161,214,273,465,525,544,612],"purpose":[145],"this":[147,549],"report.":[148],"Methods:":[149],"between":[151,257,436],"3":[152,319],"19.75":[154],"years":[155,282,416,522],"age":[157],"who":[158],"had":[159,536],"\u22651of":[160],"following":[162],"complications":[163],"-":[164],"stroke,":[165],"high":[166,570],"transcranial":[167],"doppler":[168],"velocity,":[169],"recurrent":[170],"acute":[171,370],"chest":[172],"syndrome,":[173],"or":[174,231,485,523],"significant":[175],"vaso-occlusive":[176],"pain":[177],"crises":[178],"eligible.":[180],"An":[181],"independent":[182],"review":[183],"committee":[184],"confirmed":[185],"eligibility.":[186],"preparative":[188],"consisted":[190,228],"alemtuzumab":[192],"(48":[193],"mg)":[194],"(day-22":[195],"-19),":[197],"fludarabine":[198],"(150":[199],"mg/m2)":[200],"(day-8":[201],"-4),":[203],"melphalan":[205],"(140mg/m2)":[206],"(day-3).":[207],"Donors":[208],"recipients":[210],"at":[213,217,272,372,387,417,520,524],"allele-level":[216],"HLA-A,":[218],"-B,":[219],"-C":[220],"-DRB1":[222],"loci.":[223],"Graft-versus-host":[224],"(GVHD)":[226],"prophylaxis":[227,626],"tacrolimus":[230],"cyclosporine,":[232],"methotrexate":[233],"(7.5":[234],"mg/m2)on":[235],"days":[236,440],"+1,":[237],"+3":[238],"+6,":[240],"methylprednisolone":[242],"(1":[243],"mg/kg/day)":[244],"day":[246,250,324,373],"+7,":[247],"tapered":[248],"+28.":[251],"Results:":[252],"Thirty":[253],"enrolled":[256],"2008":[258],"2014.":[260],"One":[261,421],"excluded":[264],"analysis":[266],"major":[269],"eligibility":[270],"violation":[271],"DSMB's":[274],"recommendation.":[275],"Twenty-nine":[276],"(16":[278],"M,":[279],"13F),":[280],"5.9-19.3":[281],"old":[283],"(median":[284,306,312],"14.0":[285],"years)":[286],"19":[288],"centers":[289],"median":[293],"follow":[294,532],"up":[295],"25.2":[297],"months":[298,406,468],"(range,":[299],"12-61.5":[300],"months).":[301],"recovered":[304,472],"neutrophils":[305],"12":[307,405],"days)":[308],"platelets":[310],">50x109/L":[311],"24":[313],"days).":[314],"Graft":[315],"rejection":[316],"(GR)":[317],"in":[318,395,413,458,464,493,503,548,554,560,606],"(10%)":[321],"occurred":[322,423,435,492,502,605],"before":[323],"+100,":[325],"autologous":[330],"hematopoietic":[331],"recovery.":[332],"No":[333,477],"late":[334],"GR":[335],"has":[336],"been":[337],"observed.":[338],"met":[343],"with1-year":[344],"EFS":[345,576],"76%":[347,494],"(Figure":[348,359,380,397],"1A).":[349],"1-year":[351,388,575],"probability":[352],"overall":[354],"(OS)":[356],"86%":[358],"1B).":[360],"cumulative":[362],"incidence":[363],"(CINC)":[364],"grade":[366],"II-IV":[367],"III-IV":[369],"GVHD":[371,386,392,399,604,625],"180":[374],"31%":[376],"17%":[378],"respectively":[379],"2A).":[381],"CINC":[383],"chronic":[385],"62%.":[390],"Chronic":[391,603],"extensive":[394],"38%":[396],"2B).":[398],"present":[401],"noted":[403],"post-BMT.":[407],"There":[408],"7":[410],"deaths,":[411],"all":[412,470],">14":[415],"time":[418,526],"death":[422],"second":[426],"transplant":[427],"graft":[429,589],"rejection.":[430],"other":[432],"6":[433,467],"deaths":[434],"143":[437],"960":[439],"post":[441],"BMT,":[442],"GVHD.":[444],"Non-fatal":[445],"toxicities":[446],"included":[447],"posterior":[448],"reversible":[449],"encephalopathy":[450],"syndrome":[451,484],"(PRES)":[452],"associated":[453,579],"hypertension":[455],"seizures":[457],"35%.":[459],"cases":[461],"observed":[463,596],"first":[466],"post-BMT;":[469],"no":[474],"obvious":[475],"sequelae.":[476],"developed":[479],"veno-occlusive":[480],"disease,":[481],"idiopathic":[482],"pneumonia":[483],"cerebral":[486],"hemorrhage.":[487],"Infections":[488],"common,":[490],"patients.":[496],"CMV":[497],"EBV":[499],"reactivation":[500],"each":[501],"23%":[504],"recipients.":[506],"Surviving":[507],"report":[509],"performance":[510,640],"scores":[511],"100%":[513],"(n=14),":[514],"90%":[515],"(n=5),":[516],"80%":[518],"(n=3)":[519],"2":[521],"last":[528,531],"assessment.":[529],"At":[530],"up,":[533],"13":[534],"successfully":[537],"discontinued":[538],"therapy.":[540],"Conclusion:":[541],"In":[542],"summary,":[543],"employed":[547],"MUD":[552],"children":[555],"resulted":[559],"low":[561],"rates":[562],"regimen-related":[564],"toxicity":[566,616],"(other":[567],"than":[568],"rate":[571],"PRES)":[573],"76%,":[578],"regression":[581],"manifestations.":[584],".":[585],"rejection/disease":[590],"recurrence":[591],"similar":[593],"conventional":[598],"HLA-identical":[599],"62%":[607],"leading":[613],"cause":[614],"Future":[619],"trials":[620],"should":[621],"focus":[622],"on":[623],"effective":[624],"URD":[628],"Secondary":[630],"outcome":[631],"analyses":[632],"including":[633],"health-related":[634],"life":[637],"neurocognitive":[639],"are":[641],"ongoing.":[642],"Disclosures":[643],"Walters:":[644],"ViaCord":[645],"AllCells,":[647],"Inc:":[648],"Other:":[649],"Medical":[650],"director.":[651],"Levine:Novartis:":[652],"Consultancy.":[653]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-03T00:00:00"}